Metastatic renal cell carcinoma (mRCC) has seen increased treatment options in recent years, including immunotherapy (IO) combinations paired with tyrosine kinase inhibitors (TKI). A meta-analysis of ...
Oral-B’s iO line is its latest range of electric toothbrushes. iO brushes feature linear magnetic drive technology, using magnets for a quieter and more effective brushing performance. We rate it as ...
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...